CDC20 is highly expressed in hepatocellular carcinoma, which is recognized as a predictor of adverse clinical outcomes and an independent prognostic factor (Zhuang, Yang & Meng, 2018). The gene discussed is CDC20; the disease is hepatocellular carcinoma.